MktsMarkets

Organon & Co.
NYSE: OGNKey statistics
OGN News
Stories mentioning OGN from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 1,460,000 | 1,507,000 | 1,602,000 | 1,594,000 | 1,513,000 | 1,592,000 | 1,582,000 | 1,607,000 |
| Cost of Goods Sold | 677,000 | 766,000 | 745,000 | 720,000 | 672,000 | 696,000 | 659,000 | 668,000 |
| Gross Profit | 783,000 | 741,000 | 857,000 | 874,000 | 841,000 | 896,000 | 923,000 | 939,000 |
| Operating Expenses | ||||||||
| Research & Development | ||||||||
| Sales General & Admin | 424,000 | 433,000 | 415,000 | 453,000 | 420,000 | 470,000 | 422,000 | 437,000 |
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | ||||||||
| Interest Income | ||||||||
| Interest Expense | 111,000 | 121,000 | 128,000 | 131,000 | 124,000 | 132,000 | 126,000 | 131,000 |
| Other Expense | ||||||||
| Pretax Income | 213,000 | (148,000) | 243,000 | 229,000 | 101,000 | 129,000 | 207,000 | 235,000 |
| Tax Provision | 67,000 | 57,000 | 83,000 | 84,000 | 14,000 | 20,000 | (152,000) | 40,000 |
| Net Income (Loss) | 146,000 | (205,000) | 160,000 | 145,000 | 87,000 | 109,000 | 359,000 | 195,000 |
| Earnings Per Share (Basic) | 0.56 | (0.79) | 0.61 | 0.56 | 0.34 | 0.42 | 1.39 | 0.76 |
| Earnings Per Share (Diluted) | 0.55 | (0.79) | 0.61 | 0.56 | 0.33 | 0.42 | 1.38 | 0.75 |
| Weighted Average Shares Outstanding (Basic) | 260,370 | 259,495 | 259,975 | 259,939 | 257,862 | 257,046 | 257,498 | 257,288 |
| Weighted Average Shares Outstanding (Diluted) | 262,896 | 260,764 | 260,653 | 260,156 | 261,001 | 259,152 | 259,757 | 258,598 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About OGN
Organon & Co. (NYSE: OGN) is a stock listed on the New York Stock Exchange under the ticker symbol OGN. It last traded at $13.84 (Oct 30, 2026, 4:00 PM ET), up 0.2% on the day. That gives Organon & a market capitalisation of $3.6B and a price-to-earnings ratio of 17.4.
Over the past 52 weeks OGN has traded between $5.69 and $13.83.
Revenue for the quarter ended Mar 31, 2026 was $1.5B; net income $146.0M. Revenue was down 3.5% from $1.5B in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $1.5B | $146.0M | 10.0% |
| Dec 31, 2025 | $1.5B | -$205.0M | -13.6% |
| Sep 30, 2025 | $1.6B | $160.0M | 10.0% |
| Jun 30, 2025 | $1.6B | $145.0M | 9.1% |
From Organon &’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…